Affidea, the largest European provider of diagnostic imaging, out-of-hospital and cancer care services continues to invest in Italy and has today announced the 100% acquisition of Istituto Radiologico Gandini, a highly reputed medical center in Biella, the Piedmont region, specialised in diagnostic imaging and senology.
Istituto Radiologico Gandini is an advanced diagnostic center with over 30 years of activity in Biella – Piedmont, with a strong reputation in radiology and senology. The center works with a medical team highly specialised in breast care, offering advanced diagnostic imaging such as MRI, mammography, bone densitometry, Doppler ultrasound, and comprehensive breast check-ups and screenings.
This investment strengthens Affidea’s presence in Italy reaching 59 medical centers, where more than 2500 professionals support the 2.3 million patients visiting our clinics each year. With this acquisition, Affidea diversifies and integrates its medical services in the Piedmont region, especially in the province of Biella, creating a model of clinical excellence that will offer patients complete care according to their different medical needs.
This acquisition is the fourth in 2023 announced by Affidea Group and the first in Italy for this year, following an impressive growth, with about 70 new centers added in the last two years, reaching nearly 330 centers across 15 countries in Europe.
Guy Blomfield, Affidea Chairman of the Board and CEO, said on the Affidea’s latest investment in Italy: "Our community-based care approach allows us to expand our range of services and our footprint across the markets in order to better respond to patients’ needs and their increased demand for timely access to high-quality medical services. We have expanded this year in 4 countries already, Italy being the latest, and these new investments allow us to add new capacity, more professionals and new multi-specialty services that enhance our portfolio in order to offer an integrated care across the communities we serve. We select clinics that can complement our portfolio with their strong local reputation, medical offering and new clinical specialties and Istituto Radiologico Gandini is a business with a well-built medical reputation, aligned with our services portfolio and high-end quality standards. We are delighted to welcome them in our European network.”
Zisis Sotiriou, SVP Regional COO, added: „Acquiring Istituto Radiologico Gandini is an important step in our development that strengthens Affidea's position in Italy. Their advanced diagnostic imaging capabilities, particularly in breast care imaging, are highly regarded and align with our commitment to providing the best possible care to our patients. We look forward to integrating Istituto Radiologico Gandini's expertise and services into our network and continuing to build on our success as a trusted provider of top-quality medical care in every market where we operate.”
Commenting on the acquisition, Fabio Silo, Country Manager of Affidea Italy, added: "Affidea Italy has seen stellar growth in the two past years. We have more than doubled our presence in the country, reaching now 59 centers and we have enhanced our medical portfolio with a wide variety of outpatient and adjacent services, that allow us to offer integrated care to our patients. The acquisition of Istituto Radiologico Gandini adds new clinical capabilities to our network and enhances our network in the Piedmont region, allowing us to serve more patients. With great pride, I welcome Istituto Radiologico Gandini into Affidea network. I look forward to working closely with them as one team with one core mission: improving millions of lives every year”.
The deal resulted from a private negotiation where Affidea’s international reputation as a trusted business partner and high-quality medical provider was the key catalyst for securing the transaction. Italy remains a key market in Affidea’s network where the clinical standards and its ability to address the high demand through an extensive healthcare infrastructure and high level of digitalisation makes it the preferred provider for private and NHS patients, doctors and payors.